Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.55 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | ALPL | P05186 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28325511 | 0.92 | MCOLN3 (0.49) | MCOLN3MEP1BACHEALPLKMT2A | |
| SCHEMBL6278523 | 0.86 | CA1 (0.44) | MCOLN3MEP1BACHEALPLKMT2A | |
| SCHEMBL1066283 | 0.85 | KMT2A (0.60) | ACHEKMT2AUSP2GAALMNA | |
| Hydrochloric Acid SCHEMBL27809966 | 0.83 | KMT2A (0.58) | ACHEKMT2AUSP2GAALMNA | |
| SCHEMBL12888826 | 0.82 | MCOLN3 (0.57) | MCOLN3MEP1BACHEALPLKMT2A | |
| SCHEMBL7525321 | 0.81 | MCOLN3 (0.39) | MCOLN3MEP1BACHEALPLKMT2A | |
| SCHEMBL51171 | 0.81 | MCOLN3 (0.55) | MCOLN3MEP1BACHEALPLKMT2A | |
| SCHEMBL29469916 | 0.81 | MCOLN3 (0.55) | MCOLN3MEP1BACHEALPLKMT2A | |
| SCHEMBL533956 | 0.81 | TRPV4 (0.68) | MCOLN3MEP1BACHEALPLKMT2A | |
| SCHEMBL13290903 | 0.81 | MCOLN3 (0.55) | MCOLN3MEP1BACHEALPLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014014472-A1 | STARCH-BASED ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-01-23 | — | — | WO | claimed |
| EP-4100001-B1 | CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF | I MED S COOP (ES) | 2025-06-25 | — | — | EP | disclosed |
| CN-111302945-B | Preparation method of 3-hydroxy-4-methoxy-2-nitrobenzoic acid | 上海再启生物技术有限公司 | 2023-06-13 | — | — | CN | disclosed |
| US-20230081080-A1 | CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF | I+MED S. COOP. (ES) | 2023-03-16 | — | — | US | disclosed |
| CN-115611877-A | Sulfonamide compound, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2023-01-17 | — | — | CN | disclosed |
| EP-4100001-A1 | CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF | I+Med S. Coop. (ES) | 2022-12-14 | — | — | EP | disclosed |
| EP-3359620-B1 | METHOD OF MONITORING A PARAMETER OF A HYDROCARBON WELL, PIPELINE OR FORMATION | JOHNSON MATTHEY PLC (GB) | 2022-11-30 | — | — | EP | disclosed |
| WO-2021156291-A1 | CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF | I+MED S. COOP. (ES) | 2021-08-12 | — | — | WO | disclosed |
| EP-3861996-A1 | CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF | I+Med S. Coop. (ES) | 2021-08-11 | — | — | EP | disclosed |
| EP-3362448-B1 | NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA | INVENTIVA (FR) | 2021-08-04 | — | — | EP | disclosed |
| CN-101087794-A | Pharmaceutical compounds | PIRAMED LTD (GB) | 2007-12-12 | — | — | CN | disclosed |
| CN-1906163-A | 4-phenylpiperidine derivatives as renin inhibitors | NOVARTIS AG (CH) | 2007-01-31 | — | — | CN | disclosed |
| CN-1867330-A | N-substituted azacycles | FMC CORP (US) | 2006-11-22 | — | — | CN | disclosed |
| CN-1277824-C | Piperazine derivatives | HOFFMANN LA ROCHE (CH) | 2006-10-04 | — | — | CN | disclosed |
| CN-1250549-C | Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands | HOFFMANN LA ROCHE (CH) | 2006-04-12 | — | — | CN | disclosed |
| CN-1533382-A | Piperazine derivatives | - | 2004-09-29 | — | — | CN | disclosed |
| CN-1522249-A | Quinoline derivatives as ligands for neuropeptide Y receptors | — | 2004-08-18 | — | — | CN | disclosed |
| CN-1483034-A | Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands | - | 2004-03-17 | — | — | CN | disclosed |
| US-6211223-B1 | BENZODIOXOL-5-YL-2-METHOXY-4-METHYLPHENYLSULFONYLAMINO-2-OXO ETHYL-1-METHYL-1HINDOLE-6-CARBOXYLIC ACID | PFIZER INC. | 2001-04-03 | — | — | US | disclosed |
| WO-1999020623-A1 | INDOLE DERIVATIVE USEFUL AS ENDOTHELIN RECEPTOR ANTAGONIST | PFIZER LIMITED (GB) | 1999-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230081080-A1 | CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF | CNR2, CNR1, FAAH | MCOLN3 543/4885MEP1B 4405/4885ACHE 791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.